<DOC>
	<DOC>NCT00187616</DOC>
	<brief_summary>This trial studies whether 3 different methods of asking patients about adverse medical events in a clinical trial affects the rate of reported side effects.</brief_summary>
	<brief_title>Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial</brief_title>
	<detailed_description>214 patients involved in a larger randomized controlled trial of the herb, saw palmetto, for benign prostatic hyperplaisa were randomly assigned to 3 different methods of adverse event ascertainment after a 1-month placebo run-in visit. Two methods of ascertainment were open ended questions, and 1 was a checklist. Patients were blinded to group assignment, but investigators were aware (single blind). All patients had taken placebo for one month, but had been told it was a study drug (single blind).</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Male, age &gt; 49, American Urological Association Symptom Index &gt; 8 Max urine flow rate &gt; 4 and &lt; 15 prior prostate cancer or surgery use of medications that affect urination severe concomitant illness</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2003</verification_date>
	<keyword>adverse events</keyword>
	<keyword>clinical trial methodology</keyword>
</DOC>